Institutional investors hold a majority ownership of INCY through the 95.50% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2016, these large investors purchased a net $3.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CITADEL ADVISORS LLC Bought 816.4 Thousand shares of Incyte Corp
SANDS CAPITAL MANAGEMENT LLC Bought 647.9 Thousand shares of Incyte Corp
MATRIX CAPITAL MANAGEMENT CO. LL... Bought 600.0 Thousand shares of Incyte Corp